Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug
medtigo_Innerpage_Leaderboard 728*90|| Oct ADVERTISEMENT The drug industry, patient advocates, and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for a controversial Alzheimer’s drug. They’ve gone as far as to accuse them of implicit racism, ageism, and discrimination against the disabled — and hinted at a lawsuit — over the decision […]